NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year-over-year uptick in fiscal first quarter revenues driven by balanced contributions from its key operating segments.

For the three months ended Dec. 31, the Cincinnati-based molecular diagnostics and life science research tools firm brought in revenue of $48 million compared to $44.8 million in the same quarter last year and beating the consensus analysts' estimate of $46.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.